Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain

Experimental Neurology
Michael R KilbournK A Frey

Abstract

The in vivo equilibrium specific binding of d-threo-[3H]methylphenidate, a radioligand for the dopamine transporter (DAT), and +-alpha-[3H]dihydrotetrabenazine, a radioligand for the vesicular monoamine transporter (VMAT2), were examined in rat brain with and without prior administration of 5 mg/kg scopolamine. Drug-treated animals exhibited a 30% increase in d-threo-[3H]methylphenidate binding to the DAT in the striatum relative to controls. No changes in specific binding of +-alpha-[3H]dihydrotetrabenazine were observed in any brain region following scopolamine pretreatment. Cholinergic drugs thus differentially affect in vivo specific binding of DAT and VMAT2 radioligands, suggesting this should be a consideration in selection of in vivo markers for imaging studies of dopaminergic terminals in the brain of animals and humans.

References

Dec 29, 1995·European Journal of Pharmacology·T Vander BorghtK Frey
Dec 1, 1996·Annals of Neurology·K A FreyD E Kuhl
Feb 15, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M B SkaddanP S Sherman
Jul 17, 2001·Pharmacology & Toxicology·K A BergströmJ Tiihonen
Aug 7, 2002·European Journal of Pharmacology·Evan L RiddleAnnette E Fleckenstein
Jan 29, 2003·Anesthesiology·John VotawMark Goodman
Feb 13, 2003·Neurology·Roger L Albin, Kirk A Frey

❮ Previous
Next ❯

Citations

Oct 31, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Jan Booij, Paul Kemp
Jul 2, 2008·The Journal of Pharmacology and Experimental Therapeutics·Trent J VolzAnnette E Fleckenstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.